期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
壮药汗衣台有效成分古伦宾、非洲防己碱对HBV启动子的影响 被引量:2
1
作者 林才志 谢海源 +6 位作者 黄振青 周艳平 甘尧 戴明明 程伟玲 王春鹏 廖丹 《中药药理与临床》 CAS CSCD 北大核心 2019年第4期72-77,共6页
目的:通过汗衣台抗HBV有效成分古伦宾、非洲防己碱对4种HBV启动子的影响研究,进一步探讨汗衣台抑制HBV病毒复制的可能机制。方法:采用CCK8法检测古伦宾、非洲防己碱对Hep G2细胞的增殖毒性,以确定它们的安全浓度;人工合成法、基因扩增... 目的:通过汗衣台抗HBV有效成分古伦宾、非洲防己碱对4种HBV启动子的影响研究,进一步探讨汗衣台抑制HBV病毒复制的可能机制。方法:采用CCK8法检测古伦宾、非洲防己碱对Hep G2细胞的增殖毒性,以确定它们的安全浓度;人工合成法、基因扩增法分别构建经典型和突变型的4种HBV启动子(S1p,S2p,Cp,Xp)调控的含荧光素酶报告基因的表达重组质粒(p Cp-Luc,p S1p-Luc,p S2p-Luc,p Xp-Luc),脂质体转染Hep G2细胞8h后,分别加入不同安全浓度的古伦宾、非洲防己碱进行干预处理,于24h、48h结束干预后进行双荧光素酶检测。结果:古伦宾对经典型S1p、S2p、Cp、Xp分别为中度(16.4%)、轻度(10.0%)、重度(20.2%,p=0.298)、明显抑制(8.9%,p=0.047);非洲防己碱对经典型S1p、S2p、Cp、Xp分别为中度(16.8%)、中度(17.7%)、重度(25.2%,p=0.199)、明显抑制(8.6%,p=0.05);阳性对照干扰素组对经典型S1p、S2p、Cp、Xp分别为中度(15.1%)、重度(22.3%)、重度(24.0%)和中度抑制(6.2%);拉米夫定对经典型S1p、S2p、Cp、Xp分别为重度(20.7%)、中度(13.4%)、中度(12.1%)和明显抑制(9.9%,p=0.046)。基因扩增法构建的4个HBV启动子S1p,S2p,Cp,Xp分别有1,1,4,4个突变点,突变后的启动子转录效率提高1.3倍~2.2倍(48 h组),但是,药物的抑制效率没有按相应比例提高,从这一角度来看,古伦宾、非洲防己碱、干扰素和拉米夫定对突变启动子的抑制作用除对Xp有明显提高外(2.3倍~3.5倍),对其余突变启动子均无明显变化甚至抑制作用下调(1/10~2/5)。结论:汗衣台抗HBV有效成分古伦宾、非洲防己碱对经典型和突变型的4种HBV启动子Cp,S1p,S2p,Xp均有不同程度的抑制作用,与干扰素和拉米夫定类似。四种药物对Xp尤其是突变型Xp有明显抑制作用,其中以干扰素最显著,提示汗衣台除了通过抑制启动子活性抗HBV以外,可能还通过抑制Xp启动子活性,继而下调X蛋白的表达,从而对HBV相关性肝癌的发生有预防作用。 展开更多
关键词 汗衣台 有效成分 hbv启动子 荧光素酶报告基因 重组质粒
原文传递
Design and choice of TFO binding and cleaving HBV core promoter
2
作者 光丽霞 袁发焕 +2 位作者 任平 奚敏 艾友平 《Journal of Medical Colleges of PLA(China)》 CAS 2003年第1期36-41,共6页
Objective: To screen a triple helix-forming oligodeoxyribonucleotide (TFO) that can bind HBV core promoter at target site with high affinity and specificity, and to observe the ability of manganese porphyrin modified ... Objective: To screen a triple helix-forming oligodeoxyribonucleotide (TFO) that can bind HBV core promoter at target site with high affinity and specificity, and to observe the ability of manganese porphyrin modified TFO to combine and cleave HBV DNA. Methods: Similar homopurine domain (1 734 - 1 754) in HBV core promoter was selected as target sequence. Several corresponding TFOs were synthesized. The affinities and specificities of TFOs binding target sequence were tested with electrophoretic mobility shift and DNase I footprinting assays. The selected best TFO was modified with manganese porphyrin and acridine. The ability of the TFO derivative to cleave HBV DNA was observed with cleavage experiment. Results: Under the condition of 371 and pH 7. 4, the TFO consisting of cytidylate and thymidylate (CT-TFO) and the parallel TFO consisting of guanylate and thymidylate (GT-TFOp) bound the target sequence weakly with Kd values much more than 10 -6 mol/L. The affinities of anti-parallel GT-TFO ( GT-TFOap) and short TFO consisting of adenine nucleotide and guanylate (AG-TFOsh) binding the target sequence were higher than those of the formers, with Kd values of 5 μ 10-7 mol/L and 2. 5 μ 10-8 mol/L respectively. Long AG-TFO (AG-TF01) had the highest binding affinity with a Kd value of 3 μ 10 -9 mol/L among all the TFOs studied for sequence specificity. In the presence of potassium monopersulfate, KHSO5, TFO modified with manganese porphyrin and acridine cleaved the target sequence where the triplex DNA formed. Conclusion: TFO containing AG or GT binds homopurine in HBV core promoter in adverse parallel direction to form triple helix. AG-TFO1 has the highest binding affinity among all the TFOs studied. After modified with manganese porphyrin, AG-TFO1 completely binds and cleaves the target HBV DNA sequence where triplex DNA is formed. 展开更多
关键词 triple helix-forming oligodeoxyribonucleotides hepatitis B virus triplex DNA
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部